openPR Logo
Press release

Global Outlook for Antiviral Drugs Market by Key Trends and Analysis 2024

08-28-2017 03:07 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Outlook for Antiviral Drugs Market by Key Trends

The global antiviral drugs market is reasonably consolidated, with Gilead Sciences holding a majority 51% share in 2015. The high level of consolidation is likely to help the global antiviral drugs market develop sustainably over the 2016-2024 forecast period, as the competitive makeup of the market is unlikely to change. Other leading players in the global antiviral drugs market include Merck & Co. Inc., Mylan NV, F. Hoffman-La Roche Ltd., GlaxoSmithKline Plc, Cipla Inc., AbbVie Inc., and Bristol-Myers Squibb Co. The lucrative opportunity in the antiviral drugs market is, however, likely to draw new players on a consistent basis, leading to the competition in the market intensifying over the coming years.

According to Transparency Market Research (TMR), the global antivirus drugs market is likely to exhibit a solid CAGR of 6.40% between 2016 and 2024. The market’s valuation is expected to rise from US$48.3 bn to US$82.9 bn over the forecast period.

Obtain Report Details @ http://www.transparencymarketresearch.com/antiviral-drugs-market.html

North America, Europe Likely to Dominate Antiviral Drugs Market

The global antiviral drugs market is segmented by region into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed countries in North America and Europe are likely to play a key role in the development of the global antiviral drugs market in the coming years due to the steady availability of advanced medical research infrastructure. North America accounted for more than 50% of the global antiviral drugs market in 2015 and is likely to retain a similar level of dominance through the 2016-2024 forecast period.

Emerging countries in Asia Pacific, Africa, and Latin America could also play important roles in the growth of the global antiviral drugs market in the coming years. The rising prevalence of viral diseases has made these regions crucial for antiviral drug development and thus are likely to carry significant commercial weightage for players in the antiviral drugs market over the coming years.

By disease indication, the global antiviral drugs market is segmented into HIV-AIDS, hepatitis, respiratory viruses, and others. The growing prevalence of AIDS is likely to keep it prominent within the international medical research field, leading to steady activity in the global antiviral drugs market in the coming years. Hepatitis has also become a key target for antiviral drugs market players and is likely to draw significant investment in the coming years.

Improving Medical Research Sector in APAC Economies Vital for Antiviral Drugs Market

One of the key drivers for the global antiviral drugs market is the steady growth of the medical research sector in emerging Asia Pacific economies such as India, China, and Japan. The rising government support in these countries to indigenous drug development and native pharmaceutical industry players has resulted in a steady opportunity for the global antiviral drugs market. Focusing on collaboration with medical research companies based in Asia Pacific could thus turn out to be a prosperous tactic for players in the global antiviral drugs market over the forecast period.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21083

The high unmet need for antiviral medication in Africa is also likely to remain a key driver for the global antiviral drugs market over the coming years. Underdeveloped countries in Africa have received firm support from several international medical bodies in order to combat the growing prevalence of viral diseases and the lack of resources to counter the problem, which has led to a promising situation for the antiviral drugs market.

The information in this preview comes from a Transparency Market Research report titled ‘Antiviral Drugs Market (Disease Indication - Hepatitis Virus Infection, HIV Infection, and Respiratory Virus Infection; Product Type - Branded Drugs and Generic Drugs; Distribution Channels - Hospital Pharmacy Store, Retail Pharmacy Store, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2024.’

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Outlook for Antiviral Drugs Market by Key Trends and Analysis 2024 here

News-ID: 687289 • Views: 174

More Releases from Transparency Market Research

Fuel Dispenser Market - Global Industry Analysis, Size, Share, Growth, Trends, a …
Albany, NY - Fuel Dispenser Market: Introduction In terms of value, the global fuel dispenser market is expected to reach ~US$ 2 Bn by 2030, expanding at a CAGR of ~4% during the forecast period. Based on volume, the global fuel dispenser market is estimated to reach 662,058 units by 2030, expanding at a CAGR of ~4% during the forecast period. In terms of type, the submersible system segment holds leading
Brazil Flavored and Functional Water Market Outlook, Gains Traction, Analysis An …
According to the report, the market will exhibit an impressive CAGR of 7.3% during the projection period. With this rate of growth, by the end of 2024, the market will be valued around US$9.4 bn. It is a considerable growth from the initial valuation recorded at US$5 bn in 2015. A new report by Transparency Market Research expects the Brazil flavored functional water market to grow at considerable pace over
Advantame Market Trends , Incredible Growth Opportunities, Volume, Value Growth …
Increasing health issues among the population led to an increase in the demand for non-caloric sweetener. In the global food and beverage market, the demand for advantame is on rising owing to its non-caloric sweetener properties. Advantame is one of the most recent, high potency low-calorie sweeteners to arrive in the food and beverage market with clean sugar-like the taste. The rising consumption of unhealthy/ comfort sugary food with high calories
Trends in the Feed ingredients - Outlook, Share and Opportunities in Grooming Re …
Escalating demand for high nutritional value meat is one of the major factor driving the growth of global feed ingredients market. In the global meat products market, safety is one of the major concern among meat manufacturers owing to stringent rules laid by government organizations during the handling, procurement, processing, storage, and distribution of animal products. The inclusion of high nutritive value feed ingredient into animal feed results in more

All 5 Releases


More Releases for Drugs

Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Tardive Dyskinesia Drugs Market
Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of